Thyroid metastasectomy

Pablo H Montero1, Tihana Ibrahimpasic, Iain J Nixon

  • 1Head and Neck Surgery Service, Department of Surgery, Memorial Sloan-Kettering Cancer, New York, New York.

Insights

Thyroid gland metastases are rare, often originating from kidney, lung, breast, or colon cancers. Surgery may help manage complications, though it rarely cures the cancer.

Area of Science:

  • Oncology
  • Endocrinology
  • Surgical Oncology

Background:

  • Metastases to the thyroid gland are infrequent occurrences in clinical practice.
  • Common primary sites include renal, lung, breast, and colon cancers, as well as melanoma.
  • Existing literature consists of limited retrospective series, highlighting a need for further investigation.

Purpose of the Study:

  • To review the current understanding of thyroid metastases.
  • To discuss the individualized treatment strategies for patients with thyroid metastases.
  • To evaluate the role and aims of surgical intervention in managing thyroidal metastatic disease.

Main Methods:

  • This review synthesizes information from existing retrospective studies and case reports.
  • Analysis focuses on common primary cancer types and patient outcomes.
  • Treatment decision-making criteria, including surgical candidacy, are examined.

Main Results:

  • Renal, lung, breast, colon cancer, and melanoma are the most frequent origins of thyroid metastases.
  • Treatment is highly individualized, contingent upon the patient's overall systemic disease status.
  • Surgical intervention is considered for selected patients, primarily to mitigate complications.

Conclusions:

  • Thyroid metastases necessitate personalized treatment plans based on systemic disease.
  • Surgical management, while not curative for most, aims to prevent severe complications from uncontrolled neck disease.
  • Further research into optimal management strategies for this rare condition is warranted.

Related Concept Videos

Graves Disease II: Pathophysiology01:24

Graves Disease II: Pathophysiology

Graves’ disease is an autoimmune disorder characterized by the production of thyroid-stimulating immunoglobulins (TSI) that activate TSH receptors, leading to excessive synthesis and release of thyroid hormones (T3 and T4) and resulting in hyperthyroidism.Among all causes of hyperthyroidism, Graves’ disease is the most common and can happen at any age, though it is more frequent in women. It produces a hypermetabolic state with features such as weight loss, tachycardia, tremor,...
59
Hyperthyroidism II: Pathophysiology01:27

Hyperthyroidism II: Pathophysiology

Hyperthyroidism is a hypermetabolic state caused by elevated levels of thyroid hormones, triiodothyronine (T3) and thyroxine (T4). It results from dysregulation at the thyroid, pituitary, or immune system level and affects multiple organ systems.PathophysiologyThe most common cause of hyperthyroidism is Graves’ disease, an autoimmune disorder in which antibodies, specifically thyroid-stimulating antibodies (TSAb), a subtype of TSH receptor antibodies (TRAb), bind to and activate TSH...
58
Hyperthyroidism I: Introduction01:25

Hyperthyroidism I: Introduction

Hyperthyroidism is a type of thyrotoxicosis characterized by the thyroid gland's overproduction of the thyroid hormones triiodothyronine (T3) and thyroxine (T4). This hormone excess increases the basal metabolic rate and enhances sensitivity to catecholamines.DiagnosisDiagnosis is based on clinical features and biochemical testing. It typically shows suppressed thyroid-stimulating hormone (TSH) levels below 0.4 mIU/L, with elevated free T3 and/or T4. Additional tests, including thyroid...
64